Bioabsorbable-polymer drug-eluting stents in acute myocardial infarction: Insights from the ULLISE registry.
Jorge A BelardiPablo LamelasPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
Limited information is available about the performance of bioabsorbable-polymer drug-eluting stents in the setting of acute myocardial infarction. Patients treated with these stents presenting with acute myocardial infarction are at higher risk of adverse events compared with stable patients. Further clinical trials are needed to fully understand the role of bioabsorbable-polymer drug-eluting stents in patients presenting with acute myocardial infarction.
Keyphrases
- acute myocardial infarction
- percutaneous coronary intervention
- left ventricular
- clinical trial
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- adverse drug
- peritoneal dialysis
- drug induced
- prognostic factors
- randomized controlled trial
- healthcare
- health information
- social media
- open label